Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil

OBJECTIVE: To evaluate the cost-effectiveness of introducing universal vaccination of adults aged 60 years with the 23-valent pneumococcal polysaccharide vaccine (PPV23) into the National Immunization Program (NIP) in Brazil. METHODS: Economic evaluation using a Markov model to compare two strategie...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: de Soárez, Patrícia Coelho, Sartori, Ana Marli Christovam, Freitas, Angela Carvalho, Nishikawa, Álvaro Mitsunori, Novaes, Hillegonda Maria Dutilh
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483239/
https://ncbi.nlm.nih.gov/pubmed/26114297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0130217
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы